AHA Comments to DEA on 2019 Controlled Substances Quotas

AHA comments on the Drug Enforcement Administration’s (DEA) notice of proposed rulemaking on aggregate production quotas for Schedule I and II controlled substances.

Related Resources

Special Bulletin
Member
The Centers for Medicare & Medicaid Services (CMS) July 10 issued a proposed rule that would establish a new alternative payment model (APM) fo
Special Bulletin
Member
The Centers for Medicare & Medicaid Services’ (CMS) Center for Medicare and Medicaid Innovation (CMMI) July 10 announced five new CMMI payment
Letter/Comment
Public
AHA's comment on HHS' Office of the National Coordinator for Health Information Technology’s proposed rule on interoperability, information blocking and the…
Letter/Comment
Public
Centers for Medicare & Medicaid Services’ (CMS) multifaceted proposed rule to promote electronic health information.
Special Bulletin
Member
The Centers for Medicare…
Advisory
Member
The Centers for Medicare…